Stay updated on AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page.

Latest updates to the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedIntroduces a unified Locations section listing California, Colorado, Georgia, Massachusetts, Missouri, New York, Ohio, Oregon, Tennessee, and Texas, replacing the former per-state location subsections.SummaryDifference1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedUnder Publications, a note clarifies that items are automatically filled from PubMed and may not be about the study, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the notice about government funding and NIH Clinical Center operating status from the page, and the page no longer displays information about whether the NIH facility is currently open. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedNo significant changes detected on the Study Details page; the content remains consistent across the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check98 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page.